HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JIANGXI BIO

19.940

-0.560-2.73%

Volume:1.76M

Turnover:35.44M

Market Cap:6.15B

PE:49.06

High:21.100

Open:20.400

Low:18.900

Close:20.500

52wk High:21.100

52wk Low:3.950

Shares:308.38M

HK Float Shares:307.00M

Volume Ratio:0.88

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.406

ROE:21.04%

ROA:12.08%

PB:10.58

PE(LYR):49.06

PS:22.39

Loading ...

Overview Company News Filings

JIANGXI BIO 2026 Interim Results: Revenue Down 16.5%, R&D Lifts Costs; Cash Surges After HK$405.83 Million IPO

Bulletin Express

JIANGXI BIO (06915) Reports Interim Results with Net Profit of RMB 14.366 Million, Down 61% Year-on-Year

Jiangxi Institute of Biological Products - Revenue for Six Months Ended June 30, 2026 Down 16.5% to Rmb83.3 Mln

THOMSON REUTERS

Jiangxi Institute of Biological Products - Adj Net Profit for Six Months Ended June 30, 2026 Down 21.7% to Rmb38.7 Mln

THOMSON REUTERS

Jiangxi Institute of Biological Products - no Dividends were Paid, Declared or Proposed During Hy

THOMSON REUTERS

Jiangxi Institute of Biological Products FY26 H1 Profit Drops 60.99% to RMB 14.37 Million; Revenue Falls 16.5% to RMB 83.29 Million

CMSC Initiates Coverage on JIANGXI BIO with "Accumulate" Rating and HK$23.6 Target Price

China Merchants Securities Starts Jiangxi Institute of Biological Products at Buy with HK$23.60 Price Target

MT Newswires Live

Jiangxi Institute of Biological Products Schedules Board Meeting to Release Interim Results

Jiangxi Bio Executive Director Buys 1.128 Million Shares Over Three Days, Stake Rises to 0.37%

Jiangxi Bio's Stock Surges Nearly 320% in Two Weeks, Reversing Its IPO Slump

Jiangxi Institute of Biological Products - Commences Veterinary Tetanus Antitoxin Production on July 20, 2026

THOMSON REUTERS

Jiangxi Bio Products Unit Chifeng Bo-en Starts Veterinary Tetanus Antitoxin Production Line

Jiangxi Bio (06915) Concludes Price Stabilization Period, Over-Allotment Option Lapses

Jiangxi Bio Ends Stabilization; Over-Allotment Option Lapses with No Additional H-Share Issuance

Bulletin Express

Jiangxi Institute of Biological Products Says Stabilizing Manager Buys 5,435,000 H Shares at Hk$7.4-hk$10.46

HK Movers | Jiangxi Bio Rallied Nearly 40% Intraday

MT Newswires Live

JIANGXI BIO Surges Over 17% to Record High After Subsidiary Obtains Veterinary Tetanus Antitoxin Approval

Jiangxi Institute of Biological Products Says Unit Obtains Approval Certificate for Veterinary Tetanus Antitoxin

Jiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/06915/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06915","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06915\",,,,,undefined,":{"symbol":"06915","market":"HK","secType":"STK","nameCN":"JIANGXI BIO","latestPrice":19.94,"timestamp":1788163726690,"preClose":20.5,"halted":0,"volume":1764500,"delay":0,"changeRate":-0.027317073170731645,"floatShares":307000000,"shares":308377319,"eps":0.40640029853179804,"marketStatus":"Not Yet Opened","change":-0.56,"latestTime":"08-31 16:08:46","open":20.4,"high":21.1,"low":18.9,"amount":35440080,"amplitude":0.107317,"askPrice":19.94,"askSize":1500,"bidPrice":19.6,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0.39668843232396084,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1782748800000,"exchange":"SEHK","adjPreClose":20.5,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.8768921886745847,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06915\",,,,,undefined,":{"symbol":"06915","floatShares":307000000,"roa":"12.08%","roe":"21.04%","lyrEps":0.4064,"volumeRatio":0.8768921886745847,"shares":308377319,"dividePrice":0,"high":21.1,"amplitude":0.107317,"preClose":20.5,"low":18.9,"week52Low":3.95,"pbRate":"10.58","psRate":"22.39","week52High":21.1,"institutionHeld":0,"latestPrice":19.94,"committee":-0.5,"eps":0.40640029853179804,"divideRate":0,"volume":1764500,"delay":0,"ttmEps":0.39668843232396084,"open":20.4,"prevYearClose":11.2,"prevWeekClose":20.5,"prevMonthClose":19.94,"prevQuarterClose":9.78,"fiveDayClose":18,"twentyDayClose":12.8,"sixtyDayClose":11.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06915\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"06915","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06915\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06915\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1787328000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06915\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06915","date":"2026-08-28","current":50.266149,"percent":1,"low":11.368674,"twenty":17.750558,"median":31.056328,"eighty":42.629759,"high":57.180101,"avg":31.193072,"sd":12.913441,"marketCap":6321735039},"quantilePoints":[{"date":"2026-07-03","current":17.947787,"twenty":17.790004,"median":17.849172,"eighty":17.908341,"marketCap":1964363522},{"date":"2026-07-10","current":12.666339,"twenty":12.041485,"median":13.811255,"eighty":17.137167,"marketCap":1384614162},{"date":"2026-07-17","current":19.086739,"twenty":12.428421,"median":14.247428,"eighty":17.908341,"marketCap":2093881996},{"date":"2026-07-24","current":36.000914,"twenty":12.671426,"median":17.750558,"eighty":25.299158,"marketCap":3950313456},{"date":"2026-07-31","current":42.889169,"twenty":12.691776,"median":19.086739,"eighty":36.000914,"marketCap":4715089207},{"date":"2026-08-07","current":26.960254,"twenty":13.811255,"median":25.241686,"eighty":35.873669,"marketCap":2969673581},{"date":"2026-08-14","current":39.144998,"twenty":14.683601,"median":26.960254,"eighty":38.662714,"marketCap":4317282466},{"date":"2026-08-21","current":44.63849,"twenty":14.976114,"median":28.865244,"eighty":39.214557,"marketCap":4934037104},{"date":"2026-08-28","current":57.180101,"twenty":17.750558,"median":31.056328,"eighty":42.629759,"marketCap":6321735039}],"updateTime":1788204569620},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06915\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141141363","title":"JIANGXI BIO 2026 Interim Results: Revenue Down 16.5%, R&D Lifts Costs; Cash Surges After HK$405.83 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1141141363","media":"Bulletin Express","labels":["SGX"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1141141363?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:26","pubTimestamp":1788171971,"startTime":"0","endTime":"0","summary":"Hong Kong – 31 Aug 2026 – JIANGXI Institute of Biological Products Inc. (JIANGXI BIO, 06915) reported a softer first half following its 30 June 2026 Main Board debut, as heavier research spending,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"JIANGXI BIO 2026 Interim Results: Revenue Down 16.5%, R&D Lifts Costs; Cash Surges After HK$405.83 Million IPO","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165377750","title":"JIANGXI BIO (06915) Reports Interim Results with Net Profit of RMB 14.366 Million, Down 61% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1165377750","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165377750?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:26","pubTimestamp":1788168381,"startTime":"0","endTime":"0","summary":"JIANGXI BIO (06915) has published its interim results for the 2026 fiscal year, with revenue reaching RMB 83.3 million, reflecting a decrease of approximately 16.5% compared to the same period last...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663761260","title":"Jiangxi Institute of Biological Products - Revenue for Six Months Ended June 30, 2026 Down 16.5% to Rmb83.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663761260","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663761260?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:19","pubTimestamp":1788167953,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407612","title":"Jiangxi Institute of Biological Products - Adj Net Profit for Six Months Ended June 30, 2026 Down 21.7% to Rmb38.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663407612?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:19","pubTimestamp":1788167953,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S05O:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06915","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076129","title":"Jiangxi Institute of Biological Products - no Dividends were Paid, Declared or Proposed During Hy","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076129","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076129?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:19","pubTimestamp":1788167953,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S05O:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076146","title":"Jiangxi Institute of Biological Products FY26 H1 Profit Drops 60.99% to RMB 14.37 Million; Revenue Falls 16.5% to RMB 83.29 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076146","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076146?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:18","pubTimestamp":1788167911,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products FY26 H1 profit drops 60.99% to RMB 14.37 million; revenue falls 16.5% to RMB 83.29 millionJiangxi Institute of Biological Products posted profit of RMB 14.37 m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL4pbxtV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173344381","title":"CMSC Initiates Coverage on JIANGXI BIO with \"Accumulate\" Rating and HK$23.6 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1173344381","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173344381?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:27","pubTimestamp":1787192844,"startTime":"0","endTime":"0","summary":"CMSC has published a research report initiating coverage on JIANGXI BIO (06915) with an \"Accumulate\" rating and a target price of HK$23.6. The brokerage highlights that the company is accelerating...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","06099","06915","BK1147","BK1161","BK1564"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404234","title":"China Merchants Securities Starts Jiangxi Institute of Biological Products at Buy with HK$23.60 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404234","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404234?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:44","pubTimestamp":1787139842,"startTime":"0","endTime":"0","summary":"China Merchants Securities Starts Jiangxi Institute of Biological Products at Buy with HK$23.60 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06915","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483106","title":"Jiangxi Institute of Biological Products Schedules Board Meeting to Release Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483106?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:34","pubTimestamp":1786955662,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products schedules board meeting to release interim resultsJiangxi Institute of Biological Products will hold a board meeting on Aug. 31, 2026.Directors are set to revi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL5G8nXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173422210","title":"Jiangxi Bio Executive Director Buys 1.128 Million Shares Over Three Days, Stake Rises to 0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173422210","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173422210?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:18","pubTimestamp":1785413906,"startTime":"0","endTime":"0","summary":"JIANGXI BIO (06915) shares experienced insider buying as executive director Jing Ruihua increased his holdings over three consecutive trading sessions.According to filings with the Hong Kong Stock...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125647376","title":"Jiangxi Bio's Stock Surges Nearly 320% in Two Weeks, Reversing Its IPO Slump","url":"https://stock-news.laohu8.com/highlight/detail?id=1125647376","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125647376?lang=en_us&edition=fundamental","pubTime":"2026-07-29 09:36","pubTimestamp":1785288989,"startTime":"0","endTime":"0","summary":"Jiangxi Bio (06915) experienced a dramatic \"V-shaped\" reversal within its first month of trading on the Hong Kong Stock Exchange, swinging from an IPO-day loss and a sharp 60% drop below its offer...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060428","title":"Jiangxi Institute of Biological Products - Commences Veterinary Tetanus Antitoxin Production on July 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060428","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060428?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:05","pubTimestamp":1785110701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43S00Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060446","title":"Jiangxi Bio Products Unit Chifeng Bo-en Starts Veterinary Tetanus Antitoxin Production Line","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060446","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060446?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:04","pubTimestamp":1785110696,"startTime":"0","endTime":"0","summary":"Jiangxi Bio Products unit Chifeng Bo-en starts veterinary tetanus antitoxin production lineChifeng Bo-en, a wholly owned unit of Jiangxi Institute of Biological Products, started production on its vet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDLb17D7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125783124","title":"Jiangxi Bio (06915) Concludes Price Stabilization Period, Over-Allotment Option Lapses","url":"https://stock-news.laohu8.com/highlight/detail?id=1125783124","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125783124?lang=en_us&edition=fundamental","pubTime":"2026-07-26 19:04","pubTimestamp":1785063851,"startTime":"0","endTime":"0","summary":"Jiangxi Bio (06915) has announced that the price stabilization period related to its global offering concluded on July 25, 2026, which is the 30th day after the deadline for submitting Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137493915","title":"Jiangxi Bio Ends Stabilization; Over-Allotment Option Lapses with No Additional H-Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=1137493915","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137493915?lang=en_us&edition=fundamental","pubTime":"2026-07-26 18:23","pubTimestamp":1785061404,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) announced that the 30-day post-listing stabilization period for its Global Offering concluded on 25 July 2026 under section 9(2) of Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654806548","title":"Jiangxi Institute of Biological Products Says Stabilizing Manager Buys 5,435,000 H Shares at Hk$7.4-hk$10.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2654806548","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654806548?lang=en_us&edition=fundamental","pubTime":"2026-07-26 18:21","pubTimestamp":1785061315,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products says stabilizing manager buys 5,435,000 H shares at HK$7.4-HK$10.46Stabilization period for the global offering ended on July 25, 2026.Stabilizing manager over-allocated 5,435,000 H shares in the international offering, about 15% of initial offer shares.Successive on-market purchases totaled 5,435,000 H shares at HK$ 7.4 to HK$ 10.46 to cover the over-allocation.Last stabilizing purchase was on June 30, 2026 at HK$ 9.78 per H share.Over-allotment option was not exercised and lapsed on July 25, 2026; no H shares will be issued under it.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Institute of Biological Products Inc. published the original content used to generate this news brief via II","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nNDL9tjJ6S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158447014","title":"HK Movers | Jiangxi Bio Rallied Nearly 40% Intraday","url":"https://stock-news.laohu8.com/highlight/detail?id=1158447014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158447014?lang=en_us&edition=fundamental","pubTime":"2026-07-24 15:40","pubTimestamp":1784878844,"startTime":"0","endTime":"0","summary":"$JIANGXI BIO(06915)$ Rallied Nearly 40% Intraday, Paring Gains to about 27%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135234202","title":"JIANGXI BIO Surges Over 17% to Record High After Subsidiary Obtains Veterinary Tetanus Antitoxin Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1135234202","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135234202?lang=en_us&edition=fundamental","pubTime":"2026-07-24 14:58","pubTimestamp":1784876310,"startTime":"0","endTime":"0","summary":"JIANGXI BIO (06915) saw its share price climb more than 17% during the trading session, reaching an intraday high of HK$12.11, a new all-time high since its listing. At the time of writing, the stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915","KCAI","VXUS","BK4585","IPOS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649309983","title":"Jiangxi Institute of Biological Products Says Unit Obtains Approval Certificate for Veterinary Tetanus Antitoxin","url":"https://stock-news.laohu8.com/highlight/detail?id=2649309983","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649309983?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:44","pubTimestamp":1783413850,"startTime":"0","endTime":"0","summary":"July 3 (Reuters) - Jiangxi Institute of Biological Products Inc <6915.HK>::*SUBSIDIARY OBTAINS APPROVAL CERTIFICATE FOR VETERINARY TETANUS ANTITOXIN*Further company coverage: 6915.HK* ((Reuters.Briefs","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSDbKvMQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198210747","title":"Jiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1198210747","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198210747?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:42","pubTimestamp":1783413761,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) released its inaugural Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in either its authorised or...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}]}}